Results 181 to 190 of about 24,058 (227)

CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia [PDF]

open access: yesMolecular Therapy, 2020
Severe congenital neutropenia (SCN) is a monogenic disorder. SCN patients are prone to recurrent life-threatening infections. The main causes of SCN are autosomal dominant mutations in the ELANE gene that lead to a block in neutrophil differentiation ...
Robin Graf   +2 more
exaly   +2 more sources

CRISPR-Cas9n-Mediated ELANE Promoter Editing for Gene Therapy of Severe Congenital Neutropenia

open access: yesMolecular Therapy
Severe congenital neutropenia (CN) is an inherited pre-leukemia bone marrow failure syndrome commonly caused by autosomal-dominant ELANE mutations (ELANE-CN).
Julia Skokowa   +2 more
exaly   +2 more sources

Dissecting ELANE Neutropenia Pathogenicity by Human HSC Gene Editing

open access: yesCell Stem Cell, 2021
SUMMARY Severe congenital neutropenia (SCN) is a life-threatening disorder most often caused by dominant mutations of ELANE that interfere with neutrophil maturation.
Daniel E. Bauer   +2 more
exaly   +2 more sources

Elan

The Modern Language Journal, 1982
The purpose of this paper is twofold: To consider the characteristics that a programming language for beginners ought to have, and to offer a new language from Germany that shows great promise for providing beginners with many of these characteristics. This language is called ELAN (Elementary LANguage) and was designed in 1974 by C. H. A.
Lyle R. Polly, Yvone Lenard
openaire   +2 more sources

Severe Congenital Neutropenia in a Multigenerational Family With a Novel Neutrophil Elastase (ELANE) Mutation

open access: yesAnnals of Hematology, 2011
We have analysed a family with nine congenital neutropenia patients in four generations, several of which we have studied in a long-term follow-up of over 25 years.
Esther van de Vosse   +2 more
exaly   +1 more source

Death in the Fas, ELANE

Cell, 2021
In this issue of Cell, Cui et al. demonstrate a previously unknown capacity for neutrophils to selectively kill cancer cells. How this killing is effected unfolds as a story of classical biochemistry, novel cell biology, and innate and adaptive immunity.
openaire   +2 more sources

ELANE: An Emerging Lane to Selective Anticancer Therapy

open access: yesSignal Transduction and Targeted Therapy, 2021
Recently, Cui et al. revealed that neutrophil elastase (ELANE) can selectively kill a wide range of cancer cells while sparing proximal non-cancer cells and significantly attenuate tumorigenesis, suggesting a promising selective and broad anticancer ...
Xianghui Fu, Jian-Kun Hu
exaly   +2 more sources

A high prevalence of neutrophil‐specific antibodies in ELANE‐mutated severe congenital neutropenia

Pediatric Blood & Cancer, 2023
An assay for neutrophil‐specific antibodies is frequently used in the workup of chronic severe neutropenia and is suggestive of autoimmune, or sporadically alloimmune neutropenia, rather than severe congenital neutropenia (SCN). We analyzed a neutropenia
W. Dobrewa   +11 more
semanticscholar   +1 more source

Absence of Neutropenia in Patient with an Exon 2 Nonsense Mutation in ELANE: Clinical Evidence to Support Gene Therapy Efforts for Severe Congenital Neutropenia

Blood, 2023
Introduction Severe congenital neutropenia (SCN) is an inherited bone marrow failure condition most often caused by heterozygous mutations in the ELANE gene.
Margret Joos   +3 more
semanticscholar   +1 more source

A Universal CRISPR/Cas9n-Mediated Genome Editing Approach for ELANE-Related Severe Congenital Neutropenia

Blood, 2023
Severe congenital neutropenia (CN) is an inherited bone marrow failure syndrome characterized by impaired maturation of neutrophil granulocytes. Due to the lack or very low levels of neutrophils in the peripheral blood, patients experience severe, life-
M. Nasri   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy